Breaking News, Collaborations & Alliances

BioNet and BIA Separations Collaborate on mRNA Manufacturing Process

Represents commitment to global efforts against COVID-19.

Author Image

By: Charlie Sternberg

Associate Editor

BioNet, a biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a biochromatography development and manufacturing company, have announced the successful development of an optimized mRNA manufacturing process.   BIA’s expertise in chromatographic columns for mRNA purification combined with BioNet’s expertise in the product development of genetic vaccines have, since early 2021, enabled both teams to collaborate on the optimization and upscale o...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters